Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more? Omar S. DinDavid DodwellRobert E. Coleman Review 16 February 2010 Pages: 525 - 538
Predictors of interobserver agreement in breast imaging using the Breast Imaging Reporting and Data System Anna Liza M. AntonioCatherine M. Crespi Review 21 February 2010 Pages: 539 - 546
Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy Lissett R. BickfordGermaine AgollahTse-Kuan Yu Preclinical study 06 May 2009 Pages: 547 - 555
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells Oliver TreeckClaus LattrichOlaf Ortmann Preclinical study 12 May 2009 Pages: 557 - 565
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer Thomas KarnDirk MetzlerAchim Rody Preclinical study 20 May 2009 Pages: 567 - 579
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells Madhavi BillamMichele D. SobolewskiNancy E. Davidson Preclinical study 21 May 2009 Pages: 581 - 592
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors Jinhua XuDezheng HuoOlufunmilayo I. Olopade Preclinical study 23 May 2009 Pages: 593 - 601
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype Hany Onsy HabashyDesmond G. PoweIan O. Ellis Preclinical study 03 June 2009 Pages: 603 - 612
Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses Mathilde Bayet-RobertDaniel MorvanChantal Barthomeuf Preclinical study 10 June 2009 Pages: 613 - 626
Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer So-Youn JungHyun Yul KimJungsil Ro Clinical trial 09 February 2010 Pages: 627 - 637
Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients Niramol ChanplakornPongsthorn ChanplakornHironobu Sasano Clinical trial 12 February 2010 Pages: 639 - 648
Effect of air travel on lymphedema risk in women with history of breast cancer Sharon L. KilbreathLeigh C. WardKatie J. Battersby Clinical trial 24 February 2010 Pages: 649 - 654
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer Michael KnauerStella MookLaura J. van ’t Veer Clinical trial 05 March 2010 Pages: 655 - 661
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer Chunhui YiLina MuDionyssios Katsaro Epidemiology 01 August 2009 Pages: 663 - 669
RETRACTED ARTICLE: Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL Charitha GangadharanMaikho ThohSunil Kumar Manna Epidemiology 02 August 2009 Pages: 671 - 683
Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer Sophie LauzierElizabeth MaunsellLouise Provencher Epidemiology 04 August 2009 Pages: 685 - 691
Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study Jianfeng LuoYu-Tang GaoQi Dai Epidemiology 04 August 2009 Pages: 693 - 702
Erratum to: Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study Jianfeng LuoYu-Tang GaoQi Dai Erratum 25 October 2009 Pages: 703 - 703
Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis Zheng HuXiang LiLi Su Epidemiology 06 August 2009 Pages: 705 - 714
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) Belinda E. KielyMark A. JenkinsKelly-Anne Phillips Epidemiology 11 August 2009 Pages: 715 - 723
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) Belinda E. KielyMark A. JenkinsKelly-Anne Phillips Erratum 04 September 2009 Pages: 725 - 726
Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Epidemiology 12 August 2009 Pages: 727 - 736
Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Epidemiology 12 August 2009 Pages: 737 - 744
Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival Rebecca J. ClevelandMarilie D. GammonRegina M. Santella Epidemiology 21 August 2009 Pages: 745 - 752
Patterns of relapse in breast cancer: changes over time Rinat YerushalmiRyan WoodsKaren Gelmon Epidemiology 22 August 2009 Pages: 753 - 759
Breast cancer-derived M543V mutation in helix 12 of estrogen receptor α inverts response to estrogen and SERMs Mark NicholsPeng ChengKenneth S. McCarty Jr Brief Report 13 June 2009 Pages: 761 - 768
Telomere length in blood cells and breast cancer risk: investigations in two case–control studies Yun-Ling ZhengChristine AmbrosoneSusan E. McCann Brief Report 19 June 2009 Pages: 769 - 775
Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome Uffe Birk JensenLone SundeMef Nilbert Brief Report 03 July 2009 Pages: 777 - 782
